Journal of Renal Nutrition
Volume 20, Issue 5 , Pages 303-308 , September 2010

Adipokines and Nutritional Status for Patients on Maintenance Hemodialysis

  • S. Małgorzewicz, MD, PhD

      Affiliations

    • Department of Clinical Nutrition, Medical University of Gdańsk, Gdańsk, Poland
    • Corresponding Author InformationAddress reprint requests to Sylwia Małgorzewicz, Department of Clinical Nutrition, Medical University of Gdańsk, Debinki str 7, 80-211 Gdańsk, Poland.
  • ,
  • E. Aleksandrowicz-Wrona, PhD

      Affiliations

    • Department of Clinical Nutrition, Medical University of Gdańsk, Gdańsk, Poland
  • ,
  • A. Owczarzak, PhD

      Affiliations

    • Department of Clinical Nutrition, Medical University of Gdańsk, Gdańsk, Poland
  • ,
  • A. Dębska-Ślizień, MD, PhD

      Affiliations

    • Department of Nephrology, Transplantology, and Internal Medicine, Medical University of Gdańsk, Gdańsk, Poland
  • ,
  • B. Rutkowski, MD, PhD

      Affiliations

    • Department of Nephrology, Transplantology, and Internal Medicine, Medical University of Gdańsk, Gdańsk, Poland
  • ,
  • W. Łysiak-Szydłowska, PhD

      Affiliations

    • Department of Clinical Nutrition, Medical University of Gdańsk, Gdańsk, Poland

References 

  1. Kalantar-Zadeh K, Abbott KC, Kronenberg F, et al. Epidemiology of dialysis patients and heart failure patients: special review article for the 25th anniversary of the Seminars in Nephrology. Semin Nephrol. 2006;26:118–133
  2. Beddhu S, Pappas LM, Ramkumar N, et al. Effects of body size and body composition on survival in hemodialysis patients. J Am Soc Nephrol. 2003;14:2366–2372
  3. Nishizawa Y, Shoji T, Ishimura E. Body composition and cardiovascular risk in hemodialysis patients. J Ren Nutr. 2006;16:241–244
  4. Honda H, Quereshi A, Heimburger O, et al. Serum albumin, C-reactive protein, interleukin-6 and fetuin A as predictors of malnutrition, cardiovascular disease and mortality in patients with end-stage renal disease. Am J Kidney Dis. 2005;47:139–148
  5. Axelsson J. Obesity in chronic kidney disease: good or bad?. Blood Purif. 2008;26:23–29
  6. Enia G, Sicuso C, Alati G, et al. Subjective global assessment of nutrition in dialysis patients. Nephrol Dial Transplant. 1993;8:1094–1099
  7. Steiber AL, Kalantar-Zadeh K, Secker D, et al. Subjective global assessment in chronic kidney disease: a review. J Ren Nutr. 2004;14:191–200
  8. Rutkowski B. Leczenie Nerkozastępcze. Czelej: Lublin; 2007;
  9. Engeli S, Feldpausch M, Gorzelniak K, et al. Association between adiponectin and mediators of inflammation in obese women. Diabetes. 2003;52:942–947
  10. Weikert C, Westphal S, Berger K, et al. Plasma resistin kevels and risk of myocardial infarction and ischemic stroke. J Clin Endocrinol Metab. 2008;93:2547–2553
  11. Pischon T, Girman CJ, Hotamisliqil GS, et al. Plasma adiponectin levels and risk of myocardial infarction in men. JAMA. 2004;14:1430–1437
  12. Ayerden EF, Ebinç H, Derici U, et al. The relationship between adiponectin levels and proinflammatory cytokines and left ventricular mass in dialysis patients. J Nephrol. 2009;22:216–223
  13. Guebe-Egziabher F, Bernhard J, Geelen G, et al. Leptin, adiponectin and ghrelin dysregulation in chronic kidney disease. J Ren Nutr. 2005;15:116–120
  14. Guebre-Egziabher F, Drai J, Fouque D. Adiponectin and chronic kidney disease. J Ren Nutr. 2007;17:9–12
  15. Więcek A, Kokot F, Chudek J, et al. The adipose tissue: a novel endocrine organ of interest to the nephrologists. Nephrol Dial Transplant. 2002;17:191–195
  16. Chudek J, Adamczak M, Kania M, et al. Does plasma leptin concentration predict the nutritional status of hemodialyzed patients with chronic renal failure?. Med Sci Monit 9:CR377-CR382. 2003;
  17. Kwan B, Beddhu S. A story half untold: adiposity, adipokines and outcomes in dialysis population. Semin Dial. 2007;20:493–497
  18. Beige J, Heipmann K, Stumvoll M, et al. Paradoxical role for adiponectin in chronic renal diseases? An example of reverse epidemiology. Exp Opin Ther Targets. 2009;13:163–173
  19. Scholze A, Tepel M. Role of leptin in reverse epidemiology in chronic kidney disease. Semin Dial. 2007;20:534–538
  20. Berg A, Combs T, Du X, et al. The adipocyte-secreted protein Acrp30 enhances hepatic insulin action. Nat Med. 2001;7:947–953
  21. Lindsay RS, Funahashi T, Hanson RL, et al. Adiponectin and development of type 2 diabetes in the Pima Indian population. Lancet. 2002;360:57–58
  22. Margetic S, Gazzola C, Pegg G, et al. Leptin: a review of its peripheral actions and interactions. Int J Obes. 2002;26:1–17
  23. Zoccali C, Mallamaci F, Tripepi G, et al. Adiponectin, metabolic risk factors, and cardiovascular events among patients with end-stage renal disease. J Am Soc Nephrol. 2002;13:134–141
  24. Diez J, Iglesias P, Fernandez-Reyes M, et al. Serum concentration of leptin, adiponectin and resistin and their relationship with cardiovascular disease in patients with end-stage renal disease. Clin Endocrinol. 2005;62:242–249
  25. Kato A, Odamaki M, Maruyama Y, et al. Association between circulating leptin and soluble receptors for tumor necrosis factor-alpha in hemodialysis patients. Clin Nephrol. 2001;56:370–377
  26. Carrero J, Aquilera A, Stenvinkel P, et al. Appetite disorders in uremia. J Ren Nutr. 2008;18:107–114
  27. Axelsson J, Heimburger O, Stanvinkel P. Adipose tissue and inflammation in chronic kidney disease. Contrib Nephrol. 2006;151:165–174
  28. Stenvinkel P, Marchlewska A, Pecoits-Filho R, et al. Adiponectin in renal disease: relationship to phenotype and genetic variation in the gene encoding adiponectin. Kidney Int. 2004;65:274–281
  29. Zanetti M, Barazzoni R, Guarinieri G. Inflammation and insulin resistance in uremia. J Ren Nutr. 2008;18:70–76
  30. Rasic-Milutinovic Z, Perunicic G, Pljesa S, et al. Metabolic syndrome in HD patients: association with body composition, nutritional status, inflammation and serum iron. Intern Med. 2000;46:945–951

PII: S1051-2276(09)00283-0

doi: 10.1053/j.jrn.2009.10.005

Journal of Renal Nutrition
Volume 20, Issue 5 , Pages 303-308 , September 2010